Cerebral Vasospasm

Front Matter....Pages I-XI
Is Cerebral Vasospasm still a Clinical Problem?....Pages 1-4
Front Matter....Pages 5-5
Pathophysiology and Molecular Genetics of Vasospasm....Pages 7-11
Identification of Genes Differentially Expressed in Canine Vasospastic Cerebral Arteries after Subarachnoid Hemorrhage....Pages 13-16
Complimentary Deoxyribonucleic Acid Array Analysis of Cerebral Arteries after Experimental Subarachnoid Hemorrhage....Pages 17-19
Which Protein Kinase C Isoforms are Involved in the Development of Vasospasm after Subarachnoid Haemorrhage?....Pages 21-24
Role of Mitogen-Activated Protein Kinase in the Contractions of Rabbit Basilar Artery Induced by Hemolysate, Oxyhemoglobin, and Bloody CSF....Pages 25-27
Apoptosis in Basilar Endothelial Cells in a Canine Double Hemorrhage Model....Pages 29-31
Delayed Clot Removal and Experimental Vasospasm....Pages 33-35
Influence of Brain Natriuretic Peptide on Phenotypic Change of Cerebral Vasculature....Pages 37-40
Brain Natriuretic Peptide and Cerebral Vasospasm in Subarachnoid Hemorrhage....Pages 41-43
Phosphatidylcholine Peroxidized by Hemoglobin Increases Intracellular Calcium in Dog Basilar Artery Smooth Muscle Cells....Pages 45-47
Importance of Rho-Kinase-Mediated Phosphorylation of Myosin Light Chain in Vasospasm....Pages 49-54
Role of MAPK in Chronic Cerebral Vasospasm....Pages 55-57
Endothelin: The “Prime Suspect” in Cerebral Vasospasm....Pages 61-65
Nitric Oxide and Vasospasm....Pages 67-72
Effect of Endothelin-Converting Enzyme Inhibitors on big Endothelin-1 Induced Contraction of Rabbit Basilar Artery....Pages 73-75
The Role of Endothelin-1 as Predictor of the Symptomatic Vasospasm in Acute Stage of Subarachnoid Haemorrhage....Pages 77-79
Gene Therapy for Vasospasm....Pages 83-87
The Functional Significance of Heme Oxygenase-1 Gene Induction in a Rat Vasospasm Model....Pages 89-91
Adenovirus-Mediated Heme Oxygenase-1 Gene Transfection Prevents Hemoglobin-Induced Contraction of Rat Basilar Artery....Pages 93-96
Front Matter....Pages 5-5
In Vivo Animal Models of Cerebral Vasospasm: A Review....Pages 99-102
Functional Characteristics of the Spasm Model by the Polystyrene Latex Bead....Pages 103-105
The Effect of Sympathetic Nervous System Exclusion on Cerebral Vasospasm Following Subarachnoid Hemorrhage in Rabbits....Pages 107-109
Comparison of Cerebral Vasospasm Between Young and Old Animals: Preliminary Report....Pages 111-114
Molecular Weight Interactions in Experimental Vasospasm....Pages 115-117
Front Matter....Pages 119-119
Diffusion-Weighted and Perfusion-Weighted MR of Cerebral Vasospasm....Pages 121-126
Assessment of Cerebral Microcirculatory Changes During Cerebral Vasospasm by Analyzing Cerebral Circulation Time on DSA Images....Pages 127-130
Bedside Monitoring of Cerebral Blood Flow in Patients with Subarachnoid Hemorrhage....Pages 131-134
Changes in Neuronal Metabolites in Brain Following Subarachnoid Haemorrhage Evaluated by Proton MR Spectroscopy....Pages 135-138
On-line Microdialysis Following Aneurysmal Subarachnoid Hemorrhage....Pages 141-144
Time Course of Various Interstitial Metabolites Following Subarachnoid Hemorrhage Studied by on-Line Microdialysis....Pages 145-147
Monitoring Subtle Neurometabolic Changes in Subarachnoid Hemorrhage Patients Using Microdialysis: A Study on 16 Cases....Pages 149-153
Microdialysis Nitric Oxide Levels and Brain Tissue Oxygen Tension in Patients with Subarachnoid Hemorrhage....Pages 155-157
Cisternal Washing Therapy for the Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage....Pages 161-165
Sequential Changes of Oxyhemoglobin in Drained Fluid of Cisternal Irrigation Therapy — Reference to the Effect of Ascorbic Acid....Pages 167-169
Cisternal Irrigation Therapy with Urokinase and Ascorbic Acid for Prevention of Vasospasm....Pages 171-174
Endovascular Treatment of Cerebral Vasospasm Following S.A.H.....Pages 177-180
Current Indications and Results of Cerebral Angioplasty....Pages 181-183
Balloon Prophylaxis of Aneurysmal Vasospasm....Pages 185-190
Effect of Intra-Arterial Infusion of Papaverine Hydrochloride on Brain Tissue Oxygen Pressure in the Management of Severe Vasospasm Following Aneurysmal Subarachnoid Hemorrhage....Pages 191-193
Front Matter....Pages 119-119
Long Term Follow up of Angioplasty for Cerebral Vasospasm....Pages 195-197
Effect of Fasudil HCl, a Protein Kinase Inhibitor, on Cerebral Vasospasm....Pages 201-204
Combined Administration of Fasudil Hydrochloride and Nitroglycerin for Treatment of Cerebral Vasospasm....Pages 205-207
Clinical Effect of Fasudil Hydrochloride for Cerebral Vasospasm Following Subarachnoid Hemorrhage....Pages 209-211
A Novel Drug Delivery System as Prophylaxis for Cerebral Vasospasm....Pages 213-215
Development of Nicardipine Prolonged-Release Implants for Preventing Vasospasm....Pages 217-220
Inhibition of Overexpression of Endothelin-1 by an RNA Synthesis Inhibitor, Doxorubicin, in the Rat Vasospasm Model....Pages 221-223
Effects of High Cervical Spinal Cord Stimulation (CSCS) on Regional Cerebral Blood Flow after Induced Subatachnoid Haemorrhage in Rats....Pages 225-227
Vasodilating Effect of Spinal Cord Stimulation for Cerebral Vasospasm....Pages 229-230
Metaanalysis of Trials of Tirilazad Mesylate in Aneurysmal SAH....Pages 233-235
Triple H Therapy after Aneurysmal Subarachnoid Hemorrhage. A Review....Pages 237-241
Triple “H” Therapy does not Increase Cerebral Blood Flow after Induced Subarachnoid Hemorrhage in Pigs. Results of a Pilot 99m TC-HMPAO-Single Photon Emission Computed Tomography Study....Pages 243-246
Cerebral Vasospasm after Subarachnoid Hemorrhage: Hypertensive Hypervolemic Hemodilution (Triple-H) Therapy According to new Systemic Hemodynamic Parameters....Pages 247-250
Antiischemic Therapy of Severe Prolonged Vasospasm after Aneurysmal SAH: Effects on Quality of Life....Pages 251-254
Hypothermia Reduces Acute Vasospasm Following SAH in Rats....Pages 255-258
Neuroprotective Treatment Paradigms in Neurovascular Surgery — Efficacy in a Rat Model of Focal Cerebral Ischemia....Pages 259-265
Back Matter....Pages 267-272